09:18 AM EST - Conavi Medical Corp : Announced its participation in Transcatheter Cardiovascular Therapeutics 2026, taking place October 31–November 3, 2026, at the San Diego Convention Center in San Diego, California. This will be Conavi’s first TCT conference since receiving U.S. Food and Drug Administration 510(k) clearance for its next-generation hybrid intravascular ultrasound and optical coherence tomography imaging system. Conavi Medical Corp
shares V.CNVI are trading unchanged at $0.14.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=CNVI%3ACC&qmodStoryID=7933689623842360
